Calamos Wealth Management’s Novo Nordisk NVO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $488K | Sell |
7,067
-15,697
| -69% | -$1.08M | 0.02% | 240 |
|
|
2025
Q1 | $1.58M | Buy |
22,764
+3,351
| +17% | +$233K | 0.08% | 114 |
|
|
2024
Q4 | $1.67M | Sell |
19,413
-11,742
| -38% | -$1.01M | 0.08% | 109 |
|
|
2024
Q3 | $3.71M | Sell |
31,155
-18,712
| -38% | -$2.23M | 0.19% | 83 |
|
|
2024
Q2 | $7.12M | Buy |
49,867
+3,368
| +7% | +$481K | 0.38% | 62 |
|
|
2024
Q1 | $5.97M | Buy |
46,499
+926
| +2% | +$119K | 0.34% | 69 |
|
|
2023
Q4 | $4.71M | Buy |
45,573
+1,222
| +3% | +$126K | 0.3% | 70 |
|
|
2023
Q3 | $4.03M | Buy |
44,351
+1,243
| +3% | +$113K | 0.31% | 74 |
|
|
2023
Q2 | $3.49M | Sell |
43,108
-714
| -2% | -$57.8K | 0.26% | 78 |
|
|
2023
Q1 | $3.49M | Sell |
43,822
-10,120
| -19% | -$805K | 0.27% | 75 |
|
|
2022
Q4 | $3.65M | Sell |
53,942
-1,666
| -3% | -$113K | 0.28% | 79 |
|
|
2022
Q3 | $2.77M | Sell |
55,608
-5,450
| -9% | -$271K | 0.24% | 82 |
|
|
2022
Q2 | $3.4M | Buy |
61,058
+8,846
| +17% | +$493K | 0.3% | 77 |
|
|
2022
Q1 | $2.9M | Buy |
52,212
+2,460
| +5% | +$137K | 0.22% | 92 |
|
|
2021
Q4 | $2.79M | Buy |
49,752
+3,746
| +8% | +$210K | 0.2% | 94 |
|
|
2021
Q3 | $2.21M | Buy |
46,006
+876
| +2% | +$42.1K | 0.18% | 97 |
|
|
2021
Q2 | $1.89M | Buy |
45,130
+9,124
| +25% | +$382K | 0.15% | 112 |
|
|
2021
Q1 | $1.21M | Buy |
36,006
+3,850
| +12% | +$130K | 0.1% | 143 |
|
|
2020
Q4 | $1.12M | Sell |
32,156
-774
| -2% | -$27K | 0.1% | 134 |
|
|
2020
Q3 | $1.14M | Buy |
32,930
+6,142
| +23% | +$213K | 0.13% | 111 |
|
|
2020
Q2 | $877K | Buy |
26,788
+7,580
| +39% | +$248K | 0.11% | 120 |
|
|
2020
Q1 | $578K | Buy |
+19,208
| New | +$578K | 0.09% | 135 |
|
|
2013
Q3 | – | Sell |
-58,190
| Closed | -$902K | – | 228 |
|
|
2013
Q2 | $902K | Buy |
+58,190
| New | +$902K | 0.32% | 99 |
|